Author | Years | Design | Sample size* | Mean age* | BMI* | Follow-up (Mon)* | Outcome Measures |
---|---|---|---|---|---|---|---|
Leopold [9] | 2001 | Retrospective study | 16 (2.6%) | 63 | 32.5 | 45 | Revision, HSS, ROM |
Koo [24] | 2009 | Cohort study | 15/11 | 63.9 | NR | 24 | Revision, KSS, KFS, ROM |
Lee [8] | 2011 | Cohort study | 37/1613 | 60 | NR | 44 | Revision, Complications, KSS, KFS |
Dragosloveanu [14] | 2013 | Retrospective study | 8 (1.8%) | 62.8 | 34 | 12 | Revision, Complications, KSS, KFS |
Siqueir [10] | 2014 | Cohort study | 23/92 | 66.5/69.1 | 32.7/32.8 | 60.3/52 | Revision, KSS, KFS |
Shahi [22] | 2014 | Retrospective study | 15 (0.43%) | 64 | 38 | 16 | Revision, KSS, Coronal alignment |
Cao [13] | 2016 | Cohort study | 11/18 | 64.3/63.7 | 26.75/26.37 | 15.8/19.5 | Revision, KSS, KFS |
Bohl [19] | 2016 | Retrospective study | 35 (1.2%) | 62 | 34 | 99 | Revision, Complications, HSS, ROM |
Wang [12] | 2017 | Cohort study | 17/1732 | 63/60.7 | 34.4/34.6 | 51 | Revision, KSS, KFS |
White [30] | 2018 | Cohort study | 33/770 | 63.6/63.6 | 32.4/30.4 | 31.2 | Revision, Complications, KOOS, VAS |
Jin [20] | 2019 | Cohort study | 65/65 | 71.4/69.2 | 26.4/26.2 | 74.1/79.8 | Revision, KSS, WOMAC, ROM |
Motififard [28] | 2020 | Cohort study | 35/618 | 68/66 | NR | 24 | Revision, Complications, KSS, KFS, ROM |
Ni [31] | 2020 | Retrospective study | 14 | 63.6 | 27.2 | 15.6 | Revision, HSS, ROM, Coronal alignment |
Rajkumar [11] | 2020 | Case–control study | 41/82 | 65.2/64.6 | 33.8/33.9 | 58.4 | Revision, Complications, KSS, KFS, ROM |
Sun [29] | 2020 | Cohort study | 11/24 | 64.2/63.5 | 28.33/27.47 | 35.5/36 | Revision, KSS, KFS |